Aegis Capital Still Positive on Rosetta Genomics (ROSG) Following Q4 Results; Nudges Ests Higher

Go back to Aegis Capital Still Positive on Rosetta Genomics (ROSG) Following Q4 Results; Nudges Ests Higher
ROSETTA GENOMICS (NASDAQ: ROSG) Delayed: 0.43 --0 (-0%)
Previous Close $0.43    52 Week High $1.84 
Open $0.02    52 Week Low $0.55 
Day High $0.43    P/E N/A 
Day Low $0.43    EPS $0.00 
Volume 1,347